Immunovant (IMVT) PT Raised to $26 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts IMVT Hot Sheet
Price: $31.15 +0.74%
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao raised the price target on Immunovant (NASDAQ: IMVT) to $26.00 (from $21.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Nomura/Instinet Downgrades ORIX Corp (8591:JP) (IX) to Neutral
- Sony Financial Holdings (8729:JP) (SNYFY) PT Lowered to JPY180 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
